Search results for: 'pacif pacif analysis for laboratory develop'

Many technologies operate in parallel as a matter of redundancy. Others operate in parallel to facilitate change management and business transformation from an old version to a new version. It is now often said that the transformation from old stack to new stack for software development will be achieved through cloud native microservices architectu...

The year 2021 was pivotal for contact centers. Organizations grappled with the continual challenges brought on by the COVID-19 pandemic while working to meet customer demand for efficient service and an improved customer experience (CX). The contact center and CX landscape was severely affected by the disruptions caused by the pandemic, which accel...

The Asia-Pacific (APAC) contact center applications market registered growth of 5.8% to reach $719.5 million in 2019. Technology up-gradation, cloud migration, and adoption of new technologies such as analytics, automation, and self-service applications are driving market growth. Frost & Sullivan expects the APAC contact center applications market ...

Final Abstract: Australia is isolated from key international markets. Therefore, an efficient logistics supply chain to ensure seamless movement of goods is vital to compete in international markets. This research provides insights into how regional developments, new trends, and key drivers and restraints will impact the industry volume and the var...

Energy transition, which refers to the shift from fossil fuel-based systems to zero-carbon solutions, is a complex process for the global energy industry, including suppliers and users. Timelines for eliminating carbon from energy systems vary by region, but most goals including the Paris Agreement focus on achieving net zero by the second half of ...

The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

17 Jun 2021  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

Infographics

×

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...